269 related articles for article (PubMed ID: 32886748)
21. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
[TBL] [Abstract][Full Text] [Related]
22. Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.
Zhang X; Zhou S; Li X; Zhou W; Zhou Y; Cui Y; Liu X
Int J Clin Pharm; 2019 Oct; 41(5):1152-1158. PubMed ID: 31392583
[TBL] [Abstract][Full Text] [Related]
23. Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study.
Jamieson HA; Nishtala PS; Scrase R; Deely JM; Abey-Nesbit R; Connolly MJ; Hilmer SN; Abernethy DR; Schluter PJ
Drugs Aging; 2018 Jan; 35(1):73-81. PubMed ID: 29222667
[TBL] [Abstract][Full Text] [Related]
24. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls.
Dyer AH; Murphy C; Lawlor B; Kennelly SP;
Drugs Aging; 2020 Nov; 37(11):829-837. PubMed ID: 32924095
[TBL] [Abstract][Full Text] [Related]
25. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort.
Dauphinot V; Faure R; Omrani S; Goutelle S; Bourguignon L; Krolak-Salmon P; Mouchoux C
J Clin Psychopharmacol; 2014 Oct; 34(5):565-70. PubMed ID: 25133790
[TBL] [Abstract][Full Text] [Related]
26. Is the Drug Burden Index Related to Declining Functional Status at Follow-up in Community-Dwelling Seniors Consulting for Minor Injuries? Results from the Canadian Emergency Team Initiative Cohort Study.
Kröger E; Simard M; Sirois MJ; Giroux M; Sirois C; Kouladjian-O'Donnell L; Reeve E; Hilmer S; Carmichael PH; Émond M
Drugs Aging; 2019 Jan; 36(1):73-83. PubMed ID: 30378088
[TBL] [Abstract][Full Text] [Related]
27. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
[TBL] [Abstract][Full Text] [Related]
28. Associations between drug burden index and mortality in older people in residential aged care facilities.
Wilson NM; Hilmer SN; March LM; Chen JS; Gnjidic D; Mason RS; Cameron ID; Sambrook PN
Drugs Aging; 2012 Feb; 29(2):157-65. PubMed ID: 22276959
[TBL] [Abstract][Full Text] [Related]
29. Associations of drug burden index with falls, general practitioner visits, and mortality in older people.
Nishtala PS; Narayan SW; Wang T; Hilmer SN
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):753-8. PubMed ID: 24723335
[TBL] [Abstract][Full Text] [Related]
30. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study.
Gnjidic D; Bell JS; Hilmer SN; Lönnroos E; Sulkava R; Hartikainen S
Ann Med; 2012 Aug; 44(5):458-67. PubMed ID: 21495785
[TBL] [Abstract][Full Text] [Related]
31. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
32. Anticholinergic and sedative medication use in older community-dwelling people: A national population study in the Netherlands.
van der Meer HG; Taxis K; Teichert M; Griens F; Pont LG; Wouters H
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):315-321. PubMed ID: 30747477
[TBL] [Abstract][Full Text] [Related]
33. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
[TBL] [Abstract][Full Text] [Related]
34. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
[TBL] [Abstract][Full Text] [Related]
35. Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study.
Jamieson HA; Nishtala PS; Scrase R; Deely JM; Abey-Nesbit R; Hilmer SN; Abernethy DR; Berry SD; Mor V; Lacey CJ; Schluter PJ
J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1127-1133. PubMed ID: 30084928
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
37. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
[TBL] [Abstract][Full Text] [Related]
38. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
39. [Effects of polypharmacy and anticholinergic/sedative drugs on the physical/cognitive/mental related outcomes of community-dwelling elderly people: The Kawasaki Wellbeing Project].
Tanaka A; Arai Y; Hirata T; Abe Y; Oguma Y; Urushihara H
Nihon Ronen Igakkai Zasshi; 2019; 56(4):504-515. PubMed ID: 31761857
[TBL] [Abstract][Full Text] [Related]
40. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
